Kiniksa Pharmaceuticals International, plc Research and Development Expense
Kiniksa Pharmaceuticals International, plc (KNSA) reported Research and Development Expense of $27.48 million for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-04-28.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2026-04-28
- Kiniksa Pharmaceuticals International, plc research and development expense for the quarter ending 2026-03-31 was $27.48M, a 42.17% increase year-over-year.
- Kiniksa Pharmaceuticals International, plc research and development expense for the quarter ending 2025-12-31 was $34.61M, a 1.72% decline year-over-year.
- Kiniksa Pharmaceuticals International, plc research and development expense for the quarter ending 2025-09-30 was $24.17M, a 7.26% decline year-over-year.
- Kiniksa Pharmaceuticals International, plc research and development expense for the quarter ending 2025-06-30 was $18.75M, a 21.92% decline year-over-year.
- Kiniksa Pharmaceuticals International, plc research and development expense for fiscal 2025 was $96.85M, a 13.23% decline from fiscal 2024.
- Kiniksa Pharmaceuticals International, plc research and development expense for fiscal 2024 was $111.62M, a 46.69% increase from fiscal 2023.
- Kiniksa Pharmaceuticals International, plc research and development expense for fiscal 2023 was $76.10M, a 16.20% increase from fiscal 2022.
- Kiniksa Pharmaceuticals International, plc research and development expense for fiscal 2022 was $65.49M, a 34.05% decline from fiscal 2021.
| Period end | Research and Development Expense 3 month | Research and Development Expense 6 month | Research and Development Expense 9 month | Research and Development Expense 12 month |
|---|---|---|---|---|
| 2026-03-31 | $27.48M 10-Q · filed 2026-04-28 | $62.08M derived: sum of 2 quarters · filed 2026-04-28 | $86.25M derived: sum of 3 quarters · filed 2026-04-28 | $105.00M derived: sum of 4 quarters · filed 2026-04-28 |
| 2025-12-31 | $34.61M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $58.77M derived: sum of 2 quarters · filed 2026-02-24 | $77.53M derived: sum of 3 quarters · filed 2026-02-24 | $96.85M 10-K · filed 2026-02-24 |
| 2025-09-30 | $24.17M 10-Q · filed 2025-10-28 | $42.92M derived: sum of 2 quarters · filed 2025-10-28 | $62.24M 10-Q · filed 2025-10-28 | $97.46M derived: sum of 4 quarters · filed 2026-04-28 |
| 2025-06-30 | $18.75M 10-Q · filed 2025-07-29 | $38.08M 10-Q · filed 2025-07-29 | $73.29M derived: sum of 3 quarters · filed 2026-04-28 | $99.35M derived: sum of 4 quarters · filed 2026-04-28 |
| 2025-03-31 | $19.32M 10-Q · filed 2026-04-28 | $54.54M derived: sum of 2 quarters · filed 2026-04-28 | $80.60M derived: sum of 3 quarters · filed 2026-04-28 | $104.61M derived: sum of 4 quarters · filed 2026-04-28 |
| 2024-12-31 | $35.22M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $61.27M derived: sum of 2 quarters · filed 2026-02-24 | $85.29M derived: sum of 3 quarters · filed 2026-02-24 | $111.62M 10-K · filed 2026-02-24 |
| 2024-09-30 | $26.06M 10-Q · filed 2025-10-28 | $50.07M derived: sum of 2 quarters · filed 2025-10-28 | $76.41M 10-Q · filed 2025-10-28 | $96.46M derived: sum of 4 quarters · filed 2026-02-24 |
| 2024-06-30 | $24.02M 10-Q · filed 2025-07-29 | $50.35M 10-Q · filed 2025-07-29 | $70.40M derived: sum of 3 quarters · filed 2026-02-24 | $87.51M derived: sum of 4 quarters · filed 2026-02-24 |
| 2024-03-31 | $26.33M 10-Q · filed 2025-04-29 | $46.39M derived: sum of 2 quarters · filed 2026-02-24 | $63.49M derived: sum of 3 quarters · filed 2026-02-24 | $87.26M derived: sum of 4 quarters · filed 2026-02-24 |
| 2023-12-31 | $20.05M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $37.16M derived: sum of 2 quarters · filed 2026-02-24 | $60.92M derived: sum of 3 quarters · filed 2026-02-24 | $76.10M 10-K · filed 2026-02-24 |
| 2023-09-30 | $17.11M 10-Q · filed 2024-10-29 | $40.87M derived: sum of 2 quarters · filed 2024-10-29 | $56.05M 10-Q · filed 2024-10-29 | $70.44M derived: sum of 4 quarters · filed 2025-02-25 |
| 2023-06-30 | $23.77M 10-Q · filed 2024-07-25 | $38.94M 10-Q · filed 2024-07-25 | $53.33M derived: sum of 3 quarters · filed 2025-02-25 | $69.81M derived: sum of 4 quarters · filed 2025-02-25 |
| 2023-03-31 | $15.17M 10-Q · filed 2024-04-25 | $29.56M derived: sum of 2 quarters · filed 2025-02-25 | $46.05M derived: sum of 3 quarters · filed 2025-02-25 | $59.84M derived: sum of 4 quarters · filed 2025-02-25 |
| 2022-12-31 | $14.39M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-25 | $30.88M derived: sum of 2 quarters · filed 2025-02-25 | $44.67M derived: sum of 3 quarters · filed 2025-02-25 | $65.49M 10-K · filed 2025-02-25 |
| 2022-09-30 | $16.48M 10-Q · filed 2023-11-02 | $30.28M derived: sum of 2 quarters · filed 2023-11-02 | $51.10M 10-Q · filed 2023-11-02 | $78.53M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-06-30 | $13.80M 10-Q · filed 2023-08-01 | $34.62M 10-Q · filed 2023-08-01 | $62.05M derived: sum of 3 quarters · filed 2024-02-28 | $81.28M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-03-31 | $20.82M 10-Q · filed 2023-05-04 | $48.25M derived: sum of 2 quarters · filed 2024-02-28 | $67.49M derived: sum of 3 quarters · filed 2024-02-28 | $91.43M derived: sum of 4 quarters · filed 2024-02-28 |
| 2021-12-31 | $27.43M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $46.67M derived: sum of 2 quarters · filed 2024-02-28 | $70.61M derived: sum of 3 quarters · filed 2024-02-28 | $99.30M 10-K · filed 2024-02-28 |
| 2021-09-30 | $19.24M 10-Q · filed 2022-11-03 | $43.18M derived: sum of 2 quarters · filed 2022-11-03 | $71.86M 10-Q · filed 2022-11-03 | $109.26M derived: sum of 4 quarters · filed 2023-03-02 |
| 2021-06-30 | $23.95M 10-Q · filed 2022-08-04 | $52.63M 10-Q · filed 2022-08-04 | $90.03M derived: sum of 3 quarters · filed 2023-03-02 | $121.44M derived: sum of 4 quarters · filed 2023-03-02 |
| 2021-03-31 | $28.68M 10-Q · filed 2022-05-05 | $66.08M derived: sum of 2 quarters · filed 2023-03-02 | $97.50M derived: sum of 3 quarters · filed 2023-03-02 | $119.82M derived: sum of 4 quarters · filed 2023-03-02 |
| 2020-12-31 | $37.40M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-02 | $68.82M derived: sum of 2 quarters · filed 2023-03-02 | $91.14M derived: sum of 3 quarters · filed 2023-03-02 | $112.04M 10-K · filed 2023-03-02 |
| 2020-09-30 | $31.42M 10-Q · filed 2021-11-04 | $53.74M derived: sum of 2 quarters · filed 2021-11-04 | $74.64M 10-Q · filed 2021-11-04 | $97.53M derived: sum of 4 quarters · filed 2022-02-24 |
| 2020-06-30 | $22.32M 10-Q · filed 2021-08-05 | $43.23M 10-Q · filed 2021-08-05 | $66.11M derived: sum of 3 quarters · filed 2022-02-24 | $88.13M derived: sum of 4 quarters · filed 2022-02-24 |
| 2020-03-31 | $20.90M 10-Q · filed 2021-05-06 | $43.79M derived: sum of 2 quarters · filed 2022-02-24 | $65.80M derived: sum of 3 quarters · filed 2022-02-24 | $96.65M derived: sum of 4 quarters · filed 2022-02-24 |
| 2019-12-31 | $22.89M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | $44.90M derived: sum of 2 quarters · filed 2022-02-24 | $75.75M derived: sum of 3 quarters · filed 2022-02-24 | $135.00M 10-K · filed 2022-02-24 |
| 2019-09-30 | $22.01M 10-Q · filed 2020-11-05 | $52.86M derived: sum of 2 quarters · filed 2020-11-05 | $112.11M 10-Q · filed 2020-11-05 | $148.24M derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-06-30 | $30.85M 10-Q · filed 2020-08-04 | $90.10M 10-Q · filed 2020-08-04 | $126.22M derived: sum of 3 quarters · filed 2021-02-25 | $146.87M derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-03-31 | $59.25M 10-Q · filed 2020-05-04 | $95.38M derived: sum of 2 quarters · filed 2021-02-25 | $116.02M derived: sum of 3 quarters · filed 2021-02-25 | $133.22M derived: sum of 4 quarters · filed 2021-02-25 |
| 2018-12-31 | $36.12M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | $56.77M derived: sum of 2 quarters · filed 2021-02-25 | $73.97M derived: sum of 3 quarters · filed 2021-02-25 | $86.60M 10-K · filed 2021-02-25 |
| 2018-09-30 | $20.64M 10-Q · filed 2019-11-05 | $37.84M derived: sum of 2 quarters · filed 2019-11-05 | $50.48M 10-Q · filed 2019-11-05 | $80.41M derived: sum of 4 quarters · filed 2019-11-05 |
| 2018-06-30 | $17.20M 10-Q · filed 2019-08-13 | $29.83M 10-Q · filed 2019-08-13 | $59.76M derived: sum of 3 quarters · filed 2019-08-13 | $73.77M derived: sum of 4 quarters · filed 2019-08-13 |
| 2018-03-31 | $12.63M 10-Q · filed 2019-05-07 | $42.56M derived: sum of 2 quarters · filed 2019-05-07 | $56.57M derived: sum of 3 quarters · filed 2019-05-07 | $65.84M derived: sum of 4 quarters · filed 2019-05-07 |
| 2017-12-31 | $29.93M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-12 | $43.94M derived: sum of 2 quarters · filed 2019-03-12 | $53.21M derived: sum of 3 quarters · filed 2019-03-12 | $56.36M 10-K · filed 2019-03-12 |
| 2017-09-30 | $14.01M 10-Q · filed 2018-11-06 | $23.28M derived: sum of 2 quarters · filed 2018-11-06 | $26.43M 10-Q · filed 2018-11-06 | |
| 2017-06-30 | $9.27M 10-Q · filed 2018-08-06 | $12.42M 10-Q · filed 2018-08-06 |